TDC
NUTX

Thompson Davis & Co’s Nutex Health NUTX Stock Holding History

Thompson Davis & Co’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,850
Closed -$692K – 146
2024
Q4 		$692K Sell
21,850
-925
-4% -$26.4K 0.45% 32
2024
Q3 		$494K Buy
+22,775
New +$328K 0.36% 48

Other funds holding NUTX

TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OPOWM
One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Thompson Davis & Co's NUTX Position: Q1 2025 in Review

Thompson Davis & Co sold out of Nutex Health (NUTX) in Q1 2025, closing a stake of 21,850 shares — an estimated $692K sold.

Thompson Davis & Co first reported a position in NUTX in Q3 2024 and held it in 2 quarters. The position peaked at $692K in Q4 2024. 46 funds tracked by Wall St. Rank hold NUTX as of Q1 2025.

  • Thompson Davis & Co reported no remaining Nutex Health position as of Q1 2025 after selling out during the quarter.
  • Thompson Davis & Co sold 21,850 Nutex Health shares in Q1 2025, an estimated $692K.
  • Thompson Davis & Co first reported a position in Nutex Health in Q3 2024 and held it in 2 quarters.
  • Thompson Davis & Co's Nutex Health position peaked at $692K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Nutex Health as of Q1 2025.

Based on Thompson Davis & Co's 13F filing for Q1 2025, filed 13 May 2025.